1. |
RIDKER P M. Highsensitivity Creactive protein: potential adjunct for global risk assessmention the primary prevention of cardiovascular disease[J].Circulation, 2001, 103: 1813-1818.
|
2. |
RIDKER P M, RIFAI N, STAMPFER M J, et al. Plasma concentration of interleukin6 and the risk of future myocardial infarction among apparently healthymen[J]. Circulation, 2000, 101: 1767-1772.
|
3. |
PEARSON T A, MENSAH G, ALEXANDER R W,et al. Markers of inflammation and cardiovascular disease;Application to clinical and public health practice: a statement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003,107:499.
|
4. |
RIDKER P M, STAMPFER M J, RIFAI N. Novel risk factors for systemic atherosclerosis: a comparison of Creactive protein fibrinogen, homocysteine, lipoprotein(a) and standard cholesterol screening as predictors of peripheral arterial disease[J].JAMA, 2001,285:2481.
|
5. |
LIBBY P, RIDKER P M, MASERI A. Inflammation and atherosclerosis[J]. Circulation, 2002,105: 1135.
|
6. |
SAKKINEN P, ABBOTT R D, CURB J D, et al. Creactive protein and myocardial infarction[ J ]. J Clin Epidemiol, 2002, 55 (5): 445-451.
|
7. |
MUELLER C, BUETTNER H J, HODGSON J M. Inflammation and Longterm mortality after nonSTelevation acute coronary syndrome treated with a very early invasive strategy in 1 042 consecutive patients[J].Circulation,2002,105:1412.
|
8. |
ALMAGOR M, KEREN A, BANAI S. Increased C reactive protein level after coronary stent implantation in patients with stable coronary artery disease[J].Am Heart J,2003,145(2):248.
|